ARK invests $8m in Israeli cannabis co InterCure
ARK invests $8m in Israeli cannabis co InterCure ARK's Israeli ETF bought a 2.4% stake in InterCure, which is worth NIS 775 million. ARK Exchange Traded Funds (ETF) has invested $8 million in Israeli cannabis company InterCure (TASE: INCR). This is part of ARK's recent spending spree on Israeli companies after setting up an Israeli ETF. InterCure is set to merge with a SPAC (special purpose acquisition company) on the Canadian stock exchange, and ARK now has a 2.4% stake in InterCure worth NIS 775 million. ARK bought the shares at NIS 6.46, similar to today's price. RELATED ARTICLES InterCure...
Source: globes.co.il